Xilio Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 05:16 pm IST
Xilio Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 19.36 million compared to USD 24.61 million a year ago. Basic loss per share from continuing operations was USD 0.7 compared to USD 0.9 a year ago.
For the six months, net loss was USD 42 million compared to USD 45.97 million a year ago. Basic loss per share from continuing operations was USD 1.53 compared to USD 1.68 a year ago.